NCT07288736 · ACTIVE NOT RECRUITING

Aromatherapy Formulas for Sundowning and Sleep Quality in Patients With Dementia.

This trial is testing two different essential oil blends — one using rosemary and lemon in the morning paired with lavender and sweet orange in the afternoon, the other a broader calming blend — to see if aromatherapy can reduce agitation and improve sleep in people with dementia who experience sundowning. It is a Phase NA crossover study conducted in long-term care facilities in Taiwan, meaning it is exploratory in nature and not yet generating definitive proof.

You may qualify if

  • Diagnosis of dementia by a specialist according to DSM-5 (any type) OR SPMSQ score \< 8.
  • Manifesting sundown syndrome with a score ≥ 26 on the CMAI-C.
  • Able to speak Mandarin or Taiwanese.

You're excluded if

  • Clinical diagnosis of a psychiatric disorder (e.g., schizophrenia, bipolar disorder).
  • Acute stage of illness within the past 2 weeks.
  • Olfactory disorder or loss of smell (anosmia).
  • Allergy to essential oil fragrances.
  • Currently receiving aromatherapy.
  • Respiratory disease (e.g., asthma, COPD).

The sponsor's own eligibility wording, lightly reformatted. The study team makes the final eligibility decision — worth discussing with your doctor.

Eligibility criteria as of 2026-01-08

View full record on ClinicalTrials.gov

All APOE4 clinical trials